Abstract:BackgroundHepatocellular carcinoma (HCC) is the most commonly diagnosed malignancy of the liver, occurs frequently in the setting of chronic liver injury. Although multiple therapeutic approaches are available, the prognosis of patients with HCC remains poor. Dioscin is a natural steroid saponin that presents in various plants. The anti-cancer and anti-fibrotic effects have been extensively reported. However, the effect of dioscin on HCC remains unclear. We aimed to investigate the anti-HCC properties of dioscin in vitro and in vivo.MethodsMTT (3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyl-tetrazolium bromide) assay was used to analyze the growth inhibition activity of Dioscin in human cell lines, Bel-7402, HepG2, Lovo, and EAhy926. Antitumor activity through induction of apoptosis was evaluated by flow cytometry using Annexin-V and propidium iodide (PI) staining, laser scanning confocal microscopy (LSCM) analysis with Hochest33342 and PI labeling, and DNA fragmentation analysis. The expression of apoptosis-related proteins tumor protein p53 (TP53), BCL2-associated X protein (BAX), B-Cell CLL/Lymphoma 2 (BCL2) and Caspase 3 (CASP3) was measured by Western blot. Nude mice bearing Bel-7402 were administered intraperitoneally at different doses of dioscin and 5-FU (5-Fluorouracil) treatment was used as a control. Tumor volume and tumor weight of each mouse were then measured.ResultsWe demonstrated that Dioscin inhibited proliferation of HCC cell lines in a dose-dependent manner. Dioscin also significantly induced morphological changes during death by apoptosis and increased DNA damage of Bel-7402 cells. Moreover, we demonstrated that Dioscin displayed anticancer activity via up-regulating expression of TP53, BAX and CASP3 protein, as well as down-regulating BCL2 in Bel-7402 cells. Notably, the in vivo anticancer activity of Dioscin was further assessed and achieved greater inhibition efficiency at the concentration increased to 24mg/kg/day than 5-FU at dose of 10mg/kg/day in nude mice bearing Bel-7402 cells.ConclusionsDioscin inhibited tumor growth via inducing apoptosis, which was accompanied by altered expression of apoptotic pathway proteins, such as TP53, BAX, BCL2 and CASP3. Our findings indicate that further evaluation of dioscin as a novel therapeutic approach for HCC is warranted.

Dioscin Promotes Prostate Cancer Cell Apoptosis and Inhibits Cell Invasion by Increasing SHP1 Phosphorylation and Suppressing the Subsequent MAPK Signaling Pathway

Dioscin Facilitates ROS-induced Apoptosis Via the P38-Mapk/hsp27-mediated Pathways in Lung Squamous Cell Carcinoma

Dioscin-induced apoptosis of human LNCaP prostate carcinoma cells through activation of caspase-3 and modulation of Bcl-2 protein family

Dioscin Suppresses Hepatocellular Carcinoma Tumor Growth by Inducing Apoptosis and Regulation of TP53, BAX, BCL2 and Cleaved CASP3.

Dioscin Inhibits Colon Tumor Growth and Tumor Angiogenesis Through Regulating VEGFR2 and AKT/MAPK Signaling Pathways

Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins.

Dioscin inhibits SCC15 cell proliferation via the RASSF1A/MST2/YAP axis

Dioscin Inhibited Glycolysis and Induced Cell Apoptosis in Colorectal Cancer Via Promoting C-Myc Ubiquitination and Subsequent Hexokinase-2 Suppression

Dioscin Inhibits the Growth of Human Osteosarcoma by Inducing G2/M‐phase Arrest, Apoptosis, and GSDME‐dependent Cell Death in Vitro and in Vivo

Dioscin inhibits human endometrial carcinoma proliferation via G0/G1 cell cycle arrest and mitochondrial-dependent signaling pathway

Dioscin Inhibits Stem-Cell-like Properties and Tumor Growth of Osteosarcoma Through Akt/GSK3/β-catenin Signaling Pathway

Impact and mechanism study of dioscin on biological characteristics of colorectal cancer cells

Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways

Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation

Dioscin protects against chronic prostatitis through the TLR4/NF-κB pathway

Dioscin induced activation of p38 MAPK and JNK via mitochondrial pathway in HL-60 cell line.

Dioscin-6 '-O-acetate Inhibits Lung Cancer Cell Proliferation Via Inducing Cell Cycle Arrest and Caspase-Dependent Apoptosis

Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin

Dioscin Induces Gallbladder Cancer Apoptosis By Inhibiting Ros-Mediated Pi3k/Akt Signalling

Dioscin (saponin)-induced generation of reactive oxygen species through mitochondria dysfunction: a proteomic-based study.

Diosmetin Induces Modulation of Igf-1 and Il-6 Levels to Alter Rictor-Akt-PKCα Cascade in Inhibition of Prostate Cancer